- Report
- April 2023
- 110 Pages
Global
From €4217EUR$4,750USD£3,607GBP
- Report
- February 2023
- 183 Pages
From €3063EUR$3,450USD£2,620GBP
- Report
- November 2022
- 220 Pages
Global
From €3063EUR$3,450USD£2,620GBP
- Book
- March 2022
- 238 Pages
- Report
- December 2021
- 65 Pages
Global
From €4394EUR$4,950USD£3,759GBP
- Report
- January 2021
China
From €1944EUR$2,190USD£1,663GBP
- Book
- October 2019
- 346 Pages
- Training
- 15 Hours
Global
€6391EUR$7,200USD£5,467GBP
- Report
- July 2024
- 98 Pages
Global
From €3500EUR$4,224USD£3,099GBP
- Book
- July 2021
- 256 Pages
- Book
- July 2021
- 392 Pages
- Book
- October 2018
- 516 Pages
- Report
- January 2026
- 94 Pages
Global
From €3500EUR$4,224USD£3,099GBP
- Report
- October 2024
- 91 Pages
Global
From €3500EUR$4,224USD£3,099GBP
- Report
- July 2024
- 96 Pages
Global
From €3500EUR$4,224USD£3,099GBP
- Report
- June 2024
- 102 Pages
Global
From €3500EUR$4,224USD£3,099GBP
- Report
- March 2024
- 93 Pages
Global
From €3500EUR$4,224USD£3,099GBP

The Biology and Life Sciences market is a sector of the economy that focuses on the study of living organisms and their environment. It includes research and development of products and services related to the life sciences, such as biotechnology, pharmaceuticals, medical devices, and diagnostics. Companies in this market are involved in the development of new treatments and therapies, as well as the production of medical equipment and supplies.
The Biology and Life Sciences market is a rapidly growing sector, with many companies investing in research and development to create new products and services. Companies in this market are often involved in collaborations with universities and research institutions to develop new technologies and treatments.
Some of the major companies in the Biology and Life Sciences market include Amgen, Johnson & Johnson, Merck, Pfizer, and Novartis. These companies are involved in the development of new treatments and therapies, as well as the production of medical equipment and supplies. Other companies in the market include Roche, Gilead Sciences, and AbbVie. Show Less Read more